Advancing retinal disease research by unraveling underlying molecular mechanisms and developing cost-effective gene therapies using mRNA and nanoparticles.
🌟 New Year, New Website! 🌟
We’re excited to kick off 2025 with a fresh start – the Ocular Low-Cost Gene Therapy Lab website is now live! Explore our projects, meet the team, stay updated with lab news, and check out our publications. Visit us at https://t.co/KAZQD8BvnO
Miguel Seabra will be speaking at the 4th mRNA-Based Therapeutics Summit Europe (28th-30th Jan 2025, Frankfurt, Germany)! Don’t miss this opportunity to explore the latest advances in mRNA therapeutics. Read more: https://t.co/QeCyU5zhiD
#mRNA#GeneTherapy
Miguel Seabra won the NOVA Research Impact Narratives Challenge 2024! 🏆
His narrative, "Twenty years from Gene Identification to Therapeutic Intervention," showcases over two decades of pioneering work in gene therapy for retinal diseases. Read more: https://t.co/U33HrOv03I
Excited to share our latest research on isogenic stem cell models for Choroideremia, featured on the cover of Stem Cells and Development! 🌱🧬 Discover their potential for studying RPE degeneration mechanisms. Read the full paper: https://t.co/5JpytFYEwD #ChoroideremiaResearch
More exciting news! Last week, Miguel Seabra was presented with a Career Award by the Portuguese Biochemical Society, during the XXII National Congress of Biochemistry at the University of Aveiro (Portugal).
Cheers to Miguel! 🎉
Our Group Leader, Miguel Seabra, has been distinguished with the European Society for Pigment Cell Research (ESPCR) Award at the 25th annual meeting in Marseille. This honor recognizes his significant contributions to skin pigmentation research.
Congratulations, Miguel! 👏
.@TenreiroSandra da @nova_medschool está a desenvolver modelos de retina em laboratório que podem ser usados para estudar os mecanismos moleculares que levam ao desenvolvimento da retinopatia diabética.
https://t.co/0L19lAWJHC
#90SegundosCiência
📍Applications for the 7th Edition of NBR (NOVA Biomedical Research) start on March 15!
Our #MSc programme will equip you with the core skills for an outstanding career in #Biomedical research.
📅 Deadline for applications: 15.03-30.04.2023
More info 👇
https://t.co/exH35PufPJ
Today is #rareDiseaseday! We want to express out support for all patients and families who are affected by rare diseases.
In our Lab, we are dedicated to study #choroideremia, a rare chorioretinal dystrophy that causes vision loss.
@curechm@ChampalimaudF@nova_medschool
Rita Coelho defended her MSc thesis:"Characterization of cellular organelles and the endolysosomal pathway in #choroideremia patient cells" @nova_medschool, under Mafalda Silva supervision. For the great discussion, we counted on Clare Futter @UCLeye